These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26895724)

  • 21. The emerging mental health strategy of the European Union: a multi-level work-in-progress.
    Kelly BD
    Health Policy; 2008 Jan; 85(1):60-70. PubMed ID: 17643547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considerations on the EU definition of a nanomaterial: science to support policy making.
    Bleeker EA; de Jong WH; Geertsma RE; Groenewold M; Heugens EH; Koers-Jacquemijns M; van de Meent D; Popma JR; Rietveld AG; Wijnhoven SW; Cassee FR; Oomen AG
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):119-25. PubMed ID: 23200793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moving the boundaries of international collaboration on clinical trials and QoL: experiences in oncology and legislation within the European Parliament.
    Bottomley A; Kirby T; Bean J; Walker J
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):43-5. PubMed ID: 23402444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European experience in chemicals management: integrating science into policy.
    Christensen FM; Eisenreich SJ; Rasmussen K; Sintes JR; Sokull-Kluettgen B; Van de Plassche EJ
    Environ Sci Technol; 2011 Jan; 45(1):80-9. PubMed ID: 20958022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Policy decision-making under scientific uncertainty: radiological risk assessment and the role of expert advisory groups.
    Mossman KL
    Health Phys; 2009 Aug; 97(2):101-6. PubMed ID: 19590269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of social media in the environment and health professional community.
    Grossberndt S; van den Hazel P; Bartonova A
    Environ Health; 2012 Jun; 11 Suppl 1(Suppl 1):S16. PubMed ID: 22759498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advertising of medical devices: foreign experience and Ukrainian practice.
    Pashkov V; Harkusha A; Bytiak O
    Wiad Lek; 2017; 70(3 pt 1):456-461. PubMed ID: 28711887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer patients' organisation participation in heath policy decision-making: a snapshot/cluster analysis of the EU-28 countries.
    Souliotis K; Peppou LE; Tzavara C; Agapidaki E; Varvaras D; Buonomo O; Debiais D; Hasurdjiev S; Sarkozy F
    BMJ Open; 2018 Aug; 8(8):e018896. PubMed ID: 30082339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Science, policy, and the protection of human health: a European perspective.
    Martuzzi M
    Bioelectromagnetics; 2005; Suppl 7():S151-6. PubMed ID: 16059917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissolving decision making? Models and their roles in decision-making processes and policy at large.
    Zeiss R; van Egmond S
    Sci Context; 2014 Dec; 27(4):631-57. PubMed ID: 25549446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using the Advocacy Coalition Framework to understand EU pharmaceutical policy.
    Brooks E
    Eur J Public Health; 2018 Nov; 28(suppl_3):11-14. PubMed ID: 30383259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of Health Impact Assessment (HIA) in the decision-making].
    Signorelli C; Riccò M; Odone A
    Epidemiol Prev; 2011; 35(2):131-5. PubMed ID: 21628757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transposition and implementation of EU rare disease policy in Eastern Europe.
    Pejcic AV; Iskrov G; Raycheva R; Stefanov R; Jakovljevic MM
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):557-566. PubMed ID: 28975845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
    Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
    J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Empirically derived guidance for social scientists to influence environmental policy.
    Marshall N; Adger N; Attwood S; Brown K; Crissman C; Cvitanovic C; De Young C; Gooch M; James C; Jessen S; Johnson D; Marshall P; Park S; Wachenfeld D; Wrigley D
    PLoS One; 2017; 12(3):e0171950. PubMed ID: 28278238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European Community legislation and intergovernmental cooperation on migration.
    Niessen J
    Int Migr Rev; 1992; 26(2):676-84. PubMed ID: 12285278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards a sustainable EU health information system infrastructure: A consensus driven approach.
    Bogaert P; van Oers H; Van Oyen H;
    Health Policy; 2018 Dec; 122(12):1340-1347. PubMed ID: 30360999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emerging EU quality of care policy: from sharing information to enforcement.
    Vollaard H; van de Bovenkamp HM; Vrangbæk K
    Health Policy; 2013 Aug; 111(3):226-33. PubMed ID: 23764152
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.